Making chemotherapy curative: Blocking neural signalling to prevent TNBC relapse

Project: Research

Reshaping the tumour landscape: Targeting neural signalling to improve chemotherapy response and prevent relapse in TNBC

Short title	NBCF Beta-blockers and chemotherapy
Status	Finished
Effective start/end date	1/01/20 → 30/04/23

Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants
Lim, B. W. X., Li, N., Mahale, S., McInerny, S., Zethoven, M., Rowley, S. M., Huynh, J., Wang, T., Lee, J. E. A., Friedman, M., Devereux, L., Scott, R. J., Sloan, E. K., James, P. A. & Campbell, I. G., 8 Feb 2023, In: Journal of the National Cancer Institute. 115, 2, p. 181-189 9 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

6 Citations (Scopus)
Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
Tan, G. S. Q., Botteri, E., Wood, S., Sloan, E. K. & Ilomäki, J., 10 Aug 2023, In: Frontiers in Pharmacology. 14, 10 p., 1227330.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
NSAID use and unnatural deaths after cancer diagnosis: a nationwide cohort study in Sweden
Shen, Q., Sjölander, A., Sloan, E. K., Walker, A. K., Fall, K., Valdimarsdottir, U., Sparén, P., Smedby, K. E. & Fang, F., Dec 2022, In: BMC Cancer. 22, 1, 12 p., 75.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

Project Details